Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis-Reference-Cited by-同舟云学术

Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis

Published:2017-05-03 Issue:28 Volume:8 Page:46234-46248
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dengler Mirko¹,Staufer Katharina²³,Huber Heidemarie¹,Stauber Rudolf⁴,Bantel Heike⁵,Weiss Karl Heinz⁶,Starlinger Patrick⁷,Pock Hannelore⁴,Klöters-Plachky Petra⁶,Gotthardt Daniel N.⁶,Rauch Peter⁸,Lackner Carolin⁹,Stift Judith¹⁰,Brostjan Christine⁷,Gruenberger Thomas⁷,Kumada Takashi¹¹,Toyoda Hidenori¹¹,Tada Toshifumi¹¹,Weiss Thomas S.¹²,Trauner Michael³,Mikulits Wolfgang¹

Affiliation:

1. Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria

2. Department of Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria

3. Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria

4. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria

5. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany

6. University Hospital Heidelberg, Heidelberg, Germany

7. Department of Surgery, Division of General Surgery, Medical University of Vienna, Vienna, Austria

8. Candor Bioscience GmbH, Wangen im Allgäu, Germany

9. Institute of Pathology, Medical University of Graz, Graz, Austria

10. Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria

11. Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan

12. Center for Liver Cell Research, Children's University Hospital (KUNO), University of Regensburg Hospital, Regensburg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo turnover and biodistribution of soluble AXL: implications for biomarker development;Scientific Reports;2024-07-12

2. Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study;PLOS ONE;2024-07-05

3. Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH;Frontiers in Immunology;2024-05-16

4. GAS6/TAM Axis as Therapeutic Target in Liver Diseases;Seminars in Liver Disease;2024-02

5. From MASH to HCC: the role of Gas6/TAM receptors;Frontiers in Immunology;2024-01-17